Cargando…
Therapeutic Effects of Hydrogel Formulations Incorporating Troxipide Nanoparticles on Oral Mucositis in Hamsters
PURPOSE: Medical therapies, such as the use of anti-inflammatory agents, are commonly used for the treatment of oral mucositis (OM). However, these treatments have limited efficacy in treating severe cases of OM. In this study, we aimed to develop a carbopol gel incorporating troxipide (TRO) nanopar...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657765/ https://www.ncbi.nlm.nih.gov/pubmed/38024531 http://dx.doi.org/10.2147/DDDT.S433776 |
_version_ | 1785148204373770240 |
---|---|
author | Kadowaki, Reita Ogata, Fumihiko Nishida, Miku Komatsu, Miri Otake, Hiroko Nakazawa, Yosuke Yamamoto, Naoki Kawasaki, Naohito Nagai, Noriaki |
author_facet | Kadowaki, Reita Ogata, Fumihiko Nishida, Miku Komatsu, Miri Otake, Hiroko Nakazawa, Yosuke Yamamoto, Naoki Kawasaki, Naohito Nagai, Noriaki |
author_sort | Kadowaki, Reita |
collection | PubMed |
description | PURPOSE: Medical therapies, such as the use of anti-inflammatory agents, are commonly used for the treatment of oral mucositis (OM). However, these treatments have limited efficacy in treating severe cases of OM. In this study, we aimed to develop a carbopol gel incorporating troxipide (TRO) nanoparticles and methylcellulose (TRO-NP gel) and demonstrate its efficacy in accelerating wound healing in a hamster model of OM (OM model) induced by acetic acid injection. METHODS: TRO nanoparticles were prepared using bead milling. The crystalline form was determined by powder X-ray diffraction, and the particle size was measured using a NanoSight LM10 instrument. The drug release was determined using a Franz diffusion cell, and the hamsters injected with acetic acid were selected to evaluate the therapeutic effect of OM. RESULTS: After preparing TRO nanoparticles, we observed a mixture of crystals and amorphous TRO, and the particle size of TRO in the TRO-NP gel ranged from 50 to 280 nm. The TRO-NP gel exhibited a more uniform TRO distribution and viscosity compared to the Carbopol gel containing TRO microparticles (TRO-MP gel). However, the solubility of TRO was comparable in both TRO-MP and TRO-NP gels. The TRO-NP gel released a higher amount of TRO than that from the TRO-MP gel, with detectable release of TRO nanoparticles. TRO levels in the cheek pouches of hamsters treated with TRO-NP gel were higher than those treated with TRO-MP gel. The increased TRO levels in the cheek pouches of hamsters treated with TRO-NP gel were attenuated by treatment with 40 μM dynasore, an inhibitor of clathrin-dependent endocytosis (CME). Moreover, the therapeutic effect of the TRO-NP gel was superior to that of the TRO-MP gel in the hamster model of OM. CONCLUSION: We have designed a TRO-NP gel, and this gel showed excellent TRO delivery into the cheek pouch tissue through the CME pathway. Moreover, the TRO-NP gel treatment enhanced wound healing after acetic acid injection. |
format | Online Article Text |
id | pubmed-10657765 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-106577652023-11-15 Therapeutic Effects of Hydrogel Formulations Incorporating Troxipide Nanoparticles on Oral Mucositis in Hamsters Kadowaki, Reita Ogata, Fumihiko Nishida, Miku Komatsu, Miri Otake, Hiroko Nakazawa, Yosuke Yamamoto, Naoki Kawasaki, Naohito Nagai, Noriaki Drug Des Devel Ther Original Research PURPOSE: Medical therapies, such as the use of anti-inflammatory agents, are commonly used for the treatment of oral mucositis (OM). However, these treatments have limited efficacy in treating severe cases of OM. In this study, we aimed to develop a carbopol gel incorporating troxipide (TRO) nanoparticles and methylcellulose (TRO-NP gel) and demonstrate its efficacy in accelerating wound healing in a hamster model of OM (OM model) induced by acetic acid injection. METHODS: TRO nanoparticles were prepared using bead milling. The crystalline form was determined by powder X-ray diffraction, and the particle size was measured using a NanoSight LM10 instrument. The drug release was determined using a Franz diffusion cell, and the hamsters injected with acetic acid were selected to evaluate the therapeutic effect of OM. RESULTS: After preparing TRO nanoparticles, we observed a mixture of crystals and amorphous TRO, and the particle size of TRO in the TRO-NP gel ranged from 50 to 280 nm. The TRO-NP gel exhibited a more uniform TRO distribution and viscosity compared to the Carbopol gel containing TRO microparticles (TRO-MP gel). However, the solubility of TRO was comparable in both TRO-MP and TRO-NP gels. The TRO-NP gel released a higher amount of TRO than that from the TRO-MP gel, with detectable release of TRO nanoparticles. TRO levels in the cheek pouches of hamsters treated with TRO-NP gel were higher than those treated with TRO-MP gel. The increased TRO levels in the cheek pouches of hamsters treated with TRO-NP gel were attenuated by treatment with 40 μM dynasore, an inhibitor of clathrin-dependent endocytosis (CME). Moreover, the therapeutic effect of the TRO-NP gel was superior to that of the TRO-MP gel in the hamster model of OM. CONCLUSION: We have designed a TRO-NP gel, and this gel showed excellent TRO delivery into the cheek pouch tissue through the CME pathway. Moreover, the TRO-NP gel treatment enhanced wound healing after acetic acid injection. Dove 2023-11-15 /pmc/articles/PMC10657765/ /pubmed/38024531 http://dx.doi.org/10.2147/DDDT.S433776 Text en © 2023 Kadowaki et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Kadowaki, Reita Ogata, Fumihiko Nishida, Miku Komatsu, Miri Otake, Hiroko Nakazawa, Yosuke Yamamoto, Naoki Kawasaki, Naohito Nagai, Noriaki Therapeutic Effects of Hydrogel Formulations Incorporating Troxipide Nanoparticles on Oral Mucositis in Hamsters |
title | Therapeutic Effects of Hydrogel Formulations Incorporating Troxipide Nanoparticles on Oral Mucositis in Hamsters |
title_full | Therapeutic Effects of Hydrogel Formulations Incorporating Troxipide Nanoparticles on Oral Mucositis in Hamsters |
title_fullStr | Therapeutic Effects of Hydrogel Formulations Incorporating Troxipide Nanoparticles on Oral Mucositis in Hamsters |
title_full_unstemmed | Therapeutic Effects of Hydrogel Formulations Incorporating Troxipide Nanoparticles on Oral Mucositis in Hamsters |
title_short | Therapeutic Effects of Hydrogel Formulations Incorporating Troxipide Nanoparticles on Oral Mucositis in Hamsters |
title_sort | therapeutic effects of hydrogel formulations incorporating troxipide nanoparticles on oral mucositis in hamsters |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657765/ https://www.ncbi.nlm.nih.gov/pubmed/38024531 http://dx.doi.org/10.2147/DDDT.S433776 |
work_keys_str_mv | AT kadowakireita therapeuticeffectsofhydrogelformulationsincorporatingtroxipidenanoparticlesonoralmucositisinhamsters AT ogatafumihiko therapeuticeffectsofhydrogelformulationsincorporatingtroxipidenanoparticlesonoralmucositisinhamsters AT nishidamiku therapeuticeffectsofhydrogelformulationsincorporatingtroxipidenanoparticlesonoralmucositisinhamsters AT komatsumiri therapeuticeffectsofhydrogelformulationsincorporatingtroxipidenanoparticlesonoralmucositisinhamsters AT otakehiroko therapeuticeffectsofhydrogelformulationsincorporatingtroxipidenanoparticlesonoralmucositisinhamsters AT nakazawayosuke therapeuticeffectsofhydrogelformulationsincorporatingtroxipidenanoparticlesonoralmucositisinhamsters AT yamamotonaoki therapeuticeffectsofhydrogelformulationsincorporatingtroxipidenanoparticlesonoralmucositisinhamsters AT kawasakinaohito therapeuticeffectsofhydrogelformulationsincorporatingtroxipidenanoparticlesonoralmucositisinhamsters AT nagainoriaki therapeuticeffectsofhydrogelformulationsincorporatingtroxipidenanoparticlesonoralmucositisinhamsters |